PL335974A1 - Method of orally administering proteins - Google Patents

Method of orally administering proteins

Info

Publication number
PL335974A1
PL335974A1 PL98335974A PL33597498A PL335974A1 PL 335974 A1 PL335974 A1 PL 335974A1 PL 98335974 A PL98335974 A PL 98335974A PL 33597498 A PL33597498 A PL 33597498A PL 335974 A1 PL335974 A1 PL 335974A1
Authority
PL
Poland
Prior art keywords
orally administering
administering proteins
proteins
orally
administering
Prior art date
Application number
PL98335974A
Other languages
English (en)
Inventor
Nicholas A Peppas
Anthony M Lowman
Tsuneji Nagai
Mariko Morishita
Original Assignee
Purdue Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Purdue Research Foundation filed Critical Purdue Research Foundation
Publication of PL335974A1 publication Critical patent/PL335974A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
PL98335974A 1997-04-02 1998-04-02 Method of orally administering proteins PL335974A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4228097P 1997-04-02 1997-04-02
US6136797P 1997-10-08 1997-10-08

Publications (1)

Publication Number Publication Date
PL335974A1 true PL335974A1 (en) 2000-06-05

Family

ID=26719055

Family Applications (1)

Application Number Title Priority Date Filing Date
PL98335974A PL335974A1 (en) 1997-04-02 1998-04-02 Method of orally administering proteins

Country Status (14)

Country Link
EP (1) EP0975328A1 (de)
JP (1) JP2002512607A (de)
KR (1) KR20010005952A (de)
CN (1) CN1259045A (de)
AU (1) AU727053B2 (de)
BR (1) BR9808466A (de)
CA (1) CA2285457A1 (de)
IL (1) IL132176A0 (de)
NO (1) NO994757L (de)
NZ (1) NZ500075A (de)
PL (1) PL335974A1 (de)
TR (1) TR199903240T2 (de)
WO (1) WO1998043615A1 (de)
YU (1) YU49699A (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
DE10040592A1 (de) * 2000-08-15 2002-03-07 Aventis Res & Tech Gmbh & Co Formulierung zur verbesserten Aufnahme von Wirkstoffen und deren Verwendung
US6878384B2 (en) 2001-03-13 2005-04-12 Microvention, Inc. Hydrogels that undergo volumetric expansion in response to changes in their environment and their methods of manufacture and use
ES2425392T3 (es) 2002-03-20 2013-10-15 Mannkind Corporation Cartucho para un aparato de inhalación
ATE486064T1 (de) 2004-08-20 2010-11-15 Mannkind Corp Katalyse der diketopiperazinsynthese
PL1791542T3 (pl) 2004-08-23 2015-11-30 Mannkind Corp Sole diketopiperazyny do dostarczania leków
US8110212B2 (en) 2005-04-07 2012-02-07 Drexel University Bioactive thermogelling polymer systems and methods of their use
JP2009502908A (ja) 2005-07-29 2009-01-29 スティッチング グロニンゲン セントル フォー ドラッグ リサーチ ｐＨ制御パルス送達システム、その調製法及び使用法
CA2617226A1 (en) * 2005-08-01 2007-02-08 Mannkind Corporation Method of preserving the function of insulin-producing cells
AU2006290870B2 (en) 2005-09-14 2013-02-28 Mannkind Corporation Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces
EP2497484A3 (de) 2006-02-22 2012-11-07 MannKind Corporation Verfahren zur Verbesserung der pharmazeutischen Eigenschaften von Mikropartikeln mit Diketopiperazin und einem Wirkstoff
AU2007260653B2 (en) 2006-06-15 2013-01-24 Microvention, Inc. Embolization device constructed from expansible polymer
KR101567111B1 (ko) 2007-12-21 2015-11-06 마이크로벤션, 인코포레이티드 생의학 용도를 위한 히드로겔 필라멘트
DK2570147T3 (da) 2008-06-13 2018-01-29 Mannkind Corp Tørpulverinhalator og system til lægemiddelindgivelse
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
KR101628410B1 (ko) 2008-06-20 2016-06-08 맨카인드 코포레이션 흡입 활동에 관한 실시간 프로파일링을 위한 대화형 장치 및 방법
TWI532497B (zh) 2008-08-11 2016-05-11 曼凱公司 超快起作用胰島素之用途
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
CA2754595C (en) 2009-03-11 2017-06-27 Mannkind Corporation Apparatus, system and method for measuring resistance of an inhaler
US10639396B2 (en) 2015-06-11 2020-05-05 Microvention, Inc. Polymers
US8734845B2 (en) 2009-06-12 2014-05-27 Mannkind Corporation Diketopiperazine microparticles with defined specific surface areas
HUP0900482A2 (en) 2009-08-03 2011-03-28 Cera Med Kft Pharmaceutical formulation for oral administration
CA2774646A1 (en) 2009-09-24 2011-03-31 Microvention, Inc. Injectable hydrogel filaments for biomedical uses
EP2493367B1 (de) 2009-10-26 2019-03-13 Microvention, Inc. Embolisierungsvorrichtung aus einem dehnbaren polymer
CA2778698A1 (en) 2009-11-03 2011-05-12 Mannkind Corporation An apparatus and method for simulating inhalation efforts
RU2531455C2 (ru) 2010-06-21 2014-10-20 Маннкайнд Корпорейшн Системы и способы доставки сухих порошковых лекарств
MY180552A (en) 2011-04-01 2020-12-02 Mannkind Corp Blister package for pharmaceutical cartridges
WO2012145431A2 (en) 2011-04-18 2012-10-26 Microvention, Inc. Embolic devices
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
WO2013063160A1 (en) 2011-10-24 2013-05-02 Mannkind Corporation Methods and compositions for treating pain
US9011884B2 (en) 2012-04-18 2015-04-21 Microvention, Inc. Embolic devices
CA2878457C (en) 2012-07-12 2021-01-19 Mannkind Corporation Dry powder drug delivery systems and methods
WO2014066856A1 (en) 2012-10-26 2014-05-01 Mannkind Corporation Inhalable influenza vaccine compositions and methods
BR112015023168B1 (pt) 2013-03-15 2021-08-10 Mannkind Corporation Composição de 3,6-bis(n-fumaril-4-aminobutil)-2,5-dicetopiperazina cristalina, método de produção de partículas de 3,6-bis(n-fumaril-4-aminobutil)-2,5-dicetopiperazina e uso de uma composição de dicetopiperazina cristalina
CN114848614A (zh) 2013-07-18 2022-08-05 曼金德公司 热稳定性干粉药物组合物和方法
WO2015021044A1 (en) * 2013-08-05 2015-02-12 University Of Rochester Compositions and methods for stimuli-responsive release of a therapeutic agent
CA2920488C (en) 2013-08-05 2022-04-26 Mannkind Corporation Insufflation apparatus and methods
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
WO2015153996A1 (en) 2014-04-03 2015-10-08 Micro Vention, Inc. Embolic devices
US10092663B2 (en) 2014-04-29 2018-10-09 Terumo Corporation Polymers
US10226533B2 (en) 2014-04-29 2019-03-12 Microvention, Inc. Polymer filaments including pharmaceutical agents and delivering same
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
US10265405B2 (en) 2014-11-18 2019-04-23 Board Of Regents, The University Of Texas System Polymers for delivery of factor VIII and/or factor IX

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2976576A (en) * 1956-04-24 1961-03-28 Wichterle Otto Process for producing shaped articles from three-dimensional hydrophilic high polymers
US3220960A (en) * 1960-12-21 1965-11-30 Wichterle Otto Cross-linked hydrophilic polymers and articles made therefrom
DE1617393C2 (de) * 1966-01-06 1982-11-11 Československá akademie věd, Praha Verfahren zur Herstellung von biologisch aktive Stoffe enthaltenden hydrophilen vernetzten Copolymeren
US3607848A (en) * 1967-08-07 1971-09-21 Ceskoslovenska Akademie Ved Method for preparing insoluble,cross-linked organic hydrogels comprising copolymers of glycol monoesters with diesters
US3885078A (en) * 1968-03-06 1975-05-20 Ceskoslovenska Akademie Ved Hydrogel laminates and method of manufacturing thereof
US4071508A (en) * 1975-02-11 1978-01-31 Plastomedical Sciences, Inc. Anionic hydrogels based on hydroxyalkyl acrylates and methacrylates
FR2601026B1 (fr) * 1986-04-15 1988-09-16 Rhone Poulenc Chimie Matiere seche hydratable en un gel aqueux contenant des particules de polymeres dispersees, procede pour sa preparation et son application en biologie

Also Published As

Publication number Publication date
EP0975328A1 (de) 2000-02-02
NO994757L (no) 1999-11-29
AU727053B2 (en) 2000-11-30
NO994757D0 (no) 1999-09-30
TR199903240T2 (xx) 2000-05-22
NZ500075A (en) 2001-03-30
WO1998043615A1 (en) 1998-10-08
JP2002512607A (ja) 2002-04-23
IL132176A0 (en) 2001-03-19
CN1259045A (zh) 2000-07-05
BR9808466A (pt) 2001-08-07
AU6880998A (en) 1998-10-22
YU49699A (sh) 2002-12-10
KR20010005952A (ko) 2001-01-15
CA2285457A1 (en) 1998-10-08

Similar Documents

Publication Publication Date Title
PL335974A1 (en) Method of orally administering proteins
AU6883798A (en) Method of anesthesia
PL339551A1 (en) Derivatives of rezorcin
PL338633A1 (en) Derivatives of aryloxyarylsuphonylamino hydroxamic acid
EP0725145A4 (de) Methode zur proteinmodifizierung
PL339660A1 (en) Derivatives of amidocarboxylic acids
EP1033994A4 (de) Verfahren zur herstellung von bioginkgo
PL338144A1 (en) Derivatives of dolastatin 15
KR970000228A (ko) S-에토돌락의 경구용 제제
PL340461A1 (en) Derivatives of isothiazocarboxylic acid
ZA983065B (en) Inhibitors of protein farnesyltranferase
PL338579A1 (en) Method of increasing bioavailability of phexophenadin and its derivatives
PL321239A1 (en) Mutations of proteins
PL334769A1 (en) Derivatives of 5-aroylnaphtene
PL334901A1 (en) Method of obtaining benzothiazolones
PL317853A1 (en) Derivatives of amino acids
AU8271998A (en) Methods of disease detection
ZA985064B (en) Derivatives of pentaerythrits
AU7146698A (en) Method of determining three-dimensional protein structure from primary protein sequence
GB9704499D0 (en) Method of manufacture
PL335373A1 (en) Method of obtaining derivatives of 4h-4-oxoquinolysine-3-carboxylic acid
PL339304A1 (en) Method of obtaining derivatives of 1-phenylparazolin-3-carboxylic acid
IL124387A0 (en) Preparation of 5-Methyleneoxazolines
GB2329384B (en) Preparation of 1-chloro-1-cyclopropylethene
CZ119598A3 (cs) Způsob spojování dvou dílů